These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 951460)

  • 1. The effect of delta 9-tetrahydrocannabinol and LSD on the acquisition of an active avoidance response in the rat.
    Waser PG; Martin A; Heer-Carcano L
    Psychopharmacologia; 1976 Apr; 46(3):249-54. PubMed ID: 951460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of delta9-THC, LSD-25 and scopolamine on continuous, spontaneous alternation in the Y-maze.
    Drew WG; Miller LL; Baugh EL
    Psychopharmacologia; 1973; 32(2):171-82. PubMed ID: 4753532
    [No Abstract]   [Full Text] [Related]  

  • 3. Behavioral effects of prolonged administration of delta 9-tetrahydrocannabinol in the rat.
    Stiglick A; Kalant H
    Psychopharmacology (Berl); 1983; 80(4):325-30. PubMed ID: 6312481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic delta-9-tetrahydrocannabinol. Transient and lasting effects on avoidance behavior.
    Manning RJ
    Pharmacol Biochem Behav; 1976 Jan; 4(1):17-21. PubMed ID: 1265092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of 9 -THC, LSD-25 and scopolamine on non-spatial single alternation performance in the runway.
    Miller LL; Drew WG; Wikler A
    Psychopharmacologia; 1973; 28(1):1-11. PubMed ID: 4714677
    [No Abstract]   [Full Text] [Related]  

  • 6. Delta 9-Tetrahydrocannabinol, ethanol, and amphetamine as discriminative stimuli-generalization tests with other drugs.
    Bueno OF; Carlini EA; Finkelfarb E; Suzuki JS
    Psychopharmacologia; 1976 Apr; 46(3):235-43. PubMed ID: 951459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of cross-tolerance in rats among (-)delta9-trans-tetrahydrocannabinol(delta9-THC), cannabis extract, mescaline and lysergic acid diethylamide (LSD-25).
    Teresa M; Silva A; Carlini EA; Claussen U; Korte F
    Psychopharmacologia; 1968; 13(4):332-40. PubMed ID: 5722169
    [No Abstract]   [Full Text] [Related]  

  • 8. Delta 9-tetrahydrocannabinol produced discrimination in pigeons.
    Henriksson BG; Johansson JO; Järbe TU
    Pharmacol Biochem Behav; 1975; 3(5):771-4. PubMed ID: 1208619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalization of the discriminative stimulus properties of delta 9-THC to delta 9(11)-THC in rats.
    Semjonow A; Binder M
    Psychopharmacology (Berl); 1985; 85(2):178-83. PubMed ID: 2989965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delta-9-tetrahydrocannabinol and lysergic acid diethylamide: comparative changes in the supraoptic and paraventricular neurosecretory activities in rat hypothalamus.
    Biswas B; Ghosh JJ
    Anat Anz; 1975; 138(4):324-31. PubMed ID: 1108702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of delta9-tetrahydrocannabinol on active avoidance acquisition and passive avoidance retention in rats with amygdaloid lesions.
    Pandina RJ; Musty RE
    Pharmacology; 1975; 13(4):297-308. PubMed ID: 1187754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discriminative response control produced with hashish, tetrahydrocannabinols (delta 8-THC and delta 9-THC), and other drugs.
    Järbe TU; Henriksson BG
    Psychopharmacologia; 1974; 40(1):1-16. PubMed ID: 4445444
    [No Abstract]   [Full Text] [Related]  

  • 13. LSD produces place preference and flavor avoidance but does not produce flavor aversion in rats.
    Parker LA
    Behav Neurosci; 1996 Jun; 110(3):503-8. PubMed ID: 8888996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THC-induced place and taste aversions in Lewis and Sprague-Dawley rats.
    Parker LA; Gillies T
    Behav Neurosci; 1995 Feb; 109(1):71-8. PubMed ID: 7734082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conditioned taste avoidance induced by Δ(9)-tetrahydrocannabinol in the Fischer (F344) and Lewis (LEW) rat strains.
    Wakeford AG; Riley AL
    Pharmacol Biochem Behav; 2014 Jan; 116():39-44. PubMed ID: 24239786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural complexity is increased after low doses of LSD, but not moderate to high doses of oral THC or methamphetamine.
    Murray CH; Frohlich J; Haggarty CJ; Tare I; Lee R; de Wit H
    Neuropsychopharmacology; 2024 Jun; 49(7):1120-1128. PubMed ID: 38287172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerance to the effect of delta1-tetrahydrocannabinol on corticosterone levels in mouse plasma produced by repeated administration of cannabis extract or delta1-tetrahydrocannabinol.
    Pertwee RG
    Br J Pharmacol; 1974 Jul; 51(3):391-7. PubMed ID: 4451752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 9 -Tetrahydrocannabinol and ethyl alcohol: evidence for cross-tolerance in the rat.
    Newman LM; Lutz MP; Gould MH; Domino EF
    Science; 1972 Mar; 175(4025):1022-3. PubMed ID: 5061865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance to the disruptive effects of Delta(9)-THC on learning in rats.
    Delatte MS; Winsauer PJ; Moerschbaecher JM
    Pharmacol Biochem Behav; 2002 Dec; 74(1):129-40. PubMed ID: 12376160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenicity testing of 3 hallucinogens: LSD, psilocybin and delta 9-THC, using the micronucleus test.
    Van Went GF
    Experientia; 1978 Mar; 34(3):324-5. PubMed ID: 631257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.